|
1
|
Liu YZ, Du XX, Zhao QQ, Jiao Q and Jiang
H: The expression change of OTUD3-PTEN signaling axis in glioma
cells. Ann Transl Med. 8:4902020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Larjavaara S, Mäntylä R, Salminen T,
Haapasalo H, Raitanen J, Jääskeläinen J and Auvinen A: Incidence of
gliomas by anatomic location. Neuro Oncol. 9:319–325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bauchet L and Ostrom QT: Epidemiology and
molecular epidemiology. Neurosurg Clin N Am. 30:1–16. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D
and Chen J: The challenges and the promise of molecular targeted
therapy in malignant gliomas. Neoplasia. 17:239–255. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balca-Silva J, Matias D, Carmo AD,
Sarmento-Ribeiro AB, Lopes MC and Moura-Neto V: Cellular and
molecular mechanisms of glioblastoma malignancy: Implications in
resistance and therapeutic strategies. Semin Cancer Biol.
58:130–141. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Visvanathan A, Patil V, Arora A, Hegde AS,
Arivazhagan A, Santosh V and Somasundaram K: Essential role of
METTL3-mediated m6A modification in glioma stem-like
cells maintenance and radioresistance. Oncogene. 37:522–533. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y,
Zhou Y, Liu Z, Liu Y, Hu Y, et al: HBX-induced miR-5188 impairs
FOXO1 to stimulate β-catenin nuclear translocation and promotes
tumor stemness in hepatocellular carcinoma. Theranostics.
9:7583–7598. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zou Y, Lin X, Bu J, Lin Z, Chen Y, Qiu Y,
Mo H, Tang Y, Fang W and Wu Z: Timeless-stimulated
miR-5188-FOXO1/β-catenin-c-Jun feedback loop promotes stemness via
ubiquitination of β-catenin in breast cancer. Mol Ther. 28:313–327.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Camacho CV, Choudhari R and Gadad SS: Long
noncoding RNAs and cancer, an overview. Steroids. 133:93–95. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Wang W, Zhu W, Dong J, Cheng Y,
Yin Z and Shen F: Mechanisms and functions of long non-coding RNAs
at multiple regulatory levels. Int J Mol Sci. 20:55732019.
View Article : Google Scholar
|
|
11
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kiang KM, Zhang XQ and Leung GK: Long
non-coding RNAs: The key players in glioma pathogenesis. Cancers
(Basel). 7:1406–1424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang X, Xiao R, Pan S, Yang X, Yuan W, Tu
Z, Xu M, Zhu Y, Yin Q, Wu Y, et al: Uncovering the roles of long
non-coding RNAs in cancer stem cells. J Hematol Oncol. 10:622017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen
S, Wang Y, Wang T and Hou Y: Carcinoma-associated fibroblasts
promote the stemness and chemoresistance of colorectal cancer by
transferring exosomal lncRNA H19. Theranostics. 8:3932–3948. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhuang J, Shen L, Yang L, Huang X, Lu Q,
Cui Y, Zheng X, Zhao X, Zhang D, Huang R, et al: TGFβ1 promotes
gemcitabine resistance through regulating the
LncRNA-LET/NF90/miR-145 signaling axis in bladder cancer.
Theranostics. 7:3053–3067. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mazor G, Levin L, Picard D, Ahmadov U,
Carén H, Borkhardt A, Reifenberger G, Leprivier G, Remke M and
Rotblat B: The lncRNA TP73-AS1 is linked to aggressiveness in
glioblastoma and promotes temozolomide resistance in glioblastoma
cancer stem cells. Cell Death Dis. 10:2462019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L,
Li Z and Liu Y: Linc00152 promotes malignant progression of glioma
stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol
Cancer. 16:1102017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim SS, Harford JB, Moghe M, Rait A,
Pirollo KF and Chang EH: Targeted nanocomplex carrying siRNA
against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic
Acids Res. 46:1424–1440. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai X, Liao K, Zhuang Z, Chen B, Zhou Z,
Zhou S, Lin G, Zhang F, Lin Y, Miao Y, et al: AHIF promotes
glioblastoma progression and radioresistance via exosomes. Int J
Oncol. 54:261–270. 2019.PubMed/NCBI
|
|
20
|
Liao K, Ma X, Chen B, Lu X, Hu Y, Lin Y,
Huang R and Qiu Y: Upregulated AHIF-mediated radioresistance in
glioblastoma. Biochem Biophys Res Commun. 509:617–623. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng R, Yao Q, Ren C, Liu Y, Yang H, Xie
G, Du S, Yang K and Yuan Y: Upregulation of long noncoding RNA
small nucleolar RNA host gene 18 promotes radioresistance of glioma
by repressing semaphorin 5A. Int J Radiat Oncol Biol Phys.
96:877–887. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li P, Wang Q and Wang H: MicroRNA-204
inhibits the proliferation, migration and invasion of human lung
cancer cells by targeting PCNA-1 and inhibits tumor growth in
vivo. Int J Mol Med. 43:1149–1156. 2019.PubMed/NCBI
|
|
24
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeggari A, Marks DS and Larsson E:
miRcode: A map of putative microRNA target sites in the long
non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rehmsmeier M, Steffen P, Hochsmann M and
Giegerich R: Fast and effective prediction of microRNA/target
duplexes. RNA. 10:1507–1517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu
YY, Liu C, Xie YY, Zuo S, Liu Z, et al: Silencing MYH9 blocks
HBx-induced GSK3β ubiquitination and degradation to inhibit tumor
stemness in hepatocellular carcinoma. Signal Transduct Target Ther.
5:132020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Naka-Kaneda H, Nakamura S, Igarashi M, Aoi
H, Kanki H, Tsuyama J, Tsutsumi S, Aburatani H, Shimazaki T and
Okano H: The miR-17/106-p38 axis is a key regulator of the
neurogenic-to-gliogenic transition in developing neural
stem/progenitor cells. Proc Natl Acad Sci USA. 111:1604–1609. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y and Tang L: The application of
lncRNAs in cancer treatment and diagnosis. Recent Pat Anticancer
Drug Discov. 13:292–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding H, Liu J, Zou R, Cheng P and Su Y:
Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma
progression by suppressing STAT3 phosphorylation. J Exp Clin Cancer
Res. 38:1892019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ding H, Zhang X, Su Y, Jia C and Dai C:
GNAS promotes inflammation-related hepatocellular carcinoma
progression by promoting STAT3 activation. Cell Mol Biol Lett.
25:82020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao F, Wang Z, Feng Y, Zhu H, Yang M,
Zhang S and Wang X: lncRNA TPTEP1 competitively sponges miR-328-5p
to inhibit the proliferation of non-small cell lung cancer cells.
Oncol Rep. 43:1606–1618. 2020.PubMed/NCBI
|
|
36
|
Zheng J, Su Z, Kong Y, Lin Q, Liu H, Wang
Y and Wang J: lncRNAs predicted to interfere with the gene
regulation activity of miR-637 and miR-196a-5p in GBM. Front Oncol.
10:3032020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marchese FP, Raimondi I and Huarte M: The
multidimensional mechanisms of long noncoding RNA function. Genome
Biol. 18:2062017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma
LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and
miR-106a enhance the invasiveness of human glioma stem cells by
directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao H, Shen J, Hodges TR, Song R, Fuller
GN and Heimberger AB: Serum microRNA profiling in patients with
glioblastoma: A survival analysis. Mol Cancer. 16:592017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hoey C, Ray J, Jeon J, Huang X, Taeb S,
Ylanko J, Andrews DW, Boutros PC and Liu SK: miRNA-106a and
prostate cancer radioresistance: A novel role for LITAF in ATM
regulation. Mol Oncol. 12:1324–1341. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qin Y, Chen X, Liu Z, Tian X and Huo Z:
miR-106a reduces 5-fluorouracil (5-FU) sensitivity of colorectal
cancer by targeting dual-specificity phosphatases 2 (DUSP2). Med
Sci Monit. 24:4944–4951. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dong S, Zhang X and Liu D: Overexpression
of long noncoding RNA GAS5 suppresses tumorigenesis and development
of gastric cancer by sponging miR-106a-5p through the Akt/mTOR
pathway. Biol Open. 8:bio0413432019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sato A, Okada M, Shibuya K, Watanabe E,
Seino S, Narita Y, Shibui S, Kayama T and Kitanaka C: Pivotal role
for ROS activation of p38 MAPK in the control of differentiation
and tumor-initiating capacity of glioma-initiating cells. Stem Cell
Res. 12:119–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu J, Zhang H, Xu Y, Zhang J, Zhu W, Zhang
Y, Chen L, Hua W and Mao Y: Juglone induces apoptosis of tumor
stem-like cells through ROS-p38 pathway in glioblastoma. BMC
Neurol. 17:702017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu P, Brown S, Goktug T, Channathodiyil
P, Kannappan V, Hugnot JP, Guichet PO, Bian X, Armesilla AL,
Darling JL and Wang W: Cytotoxic effect of disulfiram/copper on
human glioblastoma cell lines and ALDH-positive cancer-stem-like
cells. Br J Cancer. 107:1488–1497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tamura K, Wakimoto H, Agarwal AS, Rabkin
SD, Bhere D, Martuza RL, Kuroda T, Kasmieh R and Shah K:
Multimechanistic tumor targeted oncolytic virus overcomes
resistance in brain tumors. Mol Ther. 21:68–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang W, Shen Y, Wei J and Liu F:
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and
stemness of glioma stem cells via reactive oxygen species.
Oncotarget. 6:22006–22027. 2015. View Article : Google Scholar : PubMed/NCBI
|
